A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

United States

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack, New York

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York